Current stock page

Stock Analysis

iRhythm Technologies, Inc. (IRTC) Stock Analysis

iRhythm Technologies, Inc. (IRTC) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

IRTC Stock Analysis Summary

iRhythm Technologies, Inc. (IRTC) currently has an AIQ Score of 44/100, indicating a bearish setup. Quality is the strongest factor at 58/100. Momentum is the weakest current factor at 34/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 18, 2026 · Market-close data

IRTC at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$94.87
AIQ Score44/100
Overall ViewBearish
Technical Analysis ConsensusStrong Sell
Market Cap$3.04B
P/E Ratio (TTM)-76.64
Forward P/E—
EPS (Q3 FY2026)-$0.90
Revenue (Q3 FY2026)$221.59M
Dividend Yield (TTM)0.00%
Beta0.5
Volume1.2M
52-week range$82.85-$192.47
RSI 1435.33
50-Day SMA$111.76
200-Day SMA$119.60
Analyst Price Target$177.00
Next EarningsFeb 18, 2027
As of Nov 18, 2026 · Market close

IRTCiRhythm Technologies, Inc.

Healthcare / Medical - Devices

Low Priority

Relative Laggard

BearishEdge 3/10
$94.87+$5.20 (+5.80%)

Latest quote

  • Momentum
    34
  • Value
    43
  • Quality
    58
  • Risk resilience
    44
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

IRTC Stock Analysis Summary

iRhythm Technologies, Inc. (IRTC) currently has an AIQ Score of 44/100, indicating a bearish setup. Quality is the strongest factor at 58/100. Momentum is the weakest current factor at 34/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 18, 2026 · Market-close data
AIQ Composite Posture: Bearish

In a bearish regime, IRTC has AIQ Score of 44/100 with Quality base of 58/100 and fading Momentum at 34/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Quality (58/100) leads while Momentum (34/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · 5.80% stock move · IRTC classified in Medical - Devices.

Current Evidence

BearishIRTC is in a bearish AIQ regime; Quality is the strongest visible factor at 58/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is IRTC Bullish or Bearish Right Now?

IRTC currently has a bearish overall setup. Quality is the strongest factor at 58/100, while Momentum is weakest at 34/100. The current evidence suggests a bearish setup.

Bull Case
  • - Analyst target implies +86.57% upside from the latest quote.
Bear Case
  • - Value is the current constraint at 43/100.
  • - Momentum is weak at 34/100.
  • - Risk Resilience is weak at 44/100.
  • - Price is -23.15% below its 200-day SMA.
  • - Technical consensus has more sell votes than buy votes (36 vs 7).

Current Consensus

IRTC's Technical Analysis Consensus is currently Strong Sell, with 7 buy, 3 neutral, and 36 sell votes. IRTC's 14-day RSI is 35.33, which places the stock in a weaker momentum range. IRTC's beta is 0.5, indicating lower market sensitivity than the broad market.

Signal Confidence
High agreement

What Changed in IRTC?

The largest recent change in IRTC is Momentum moving down by 23.0 points over the available 7-day comparison window. Quality remains the strongest visible factor.

AIQ Score
-8.0
Momentum
-23.0
Quality
+0.0
Risk
+1.0

What Would Change the IRTC Outlook?

The current bearish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

IRTC Decision Framework

Public evidence layers, setup checks, and risk context for iRhythm Technologies, Inc..

iRhythm Technologies, Inc. (IRTC) Stock Analysis

iRhythm Technologies, Inc. has an AIQ Score of 44/100 in a Bearish regime. Quality is strongest at 58/100. Beta is 0.5, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextIRTC is in a Bearish AIQ regime with score 44/100.
Signal ConflictThe primary conflict is that quality leads at 58/100 while momentum lags at 34/100.
Factor EvidenceMomentum 34/100 · Value 43/100 · Quality 58/100 · Risk 44/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthWait

Quality is the strongest factor at 58/100.

TimingFail

Momentum is 34/100 and RSI (14) is 35.3.

Regime fitFail

IRTC is in a Bearish regime at 44/100.

Risk controlFail

Risk factor is 44/100 with beta 0.5 and annual volatility 54.02%.

ConflictWait

Current conflict: quality leads at 58/100 while momentum lags at 34/100.

AIQ Score
44/100
Price
$94.87
Beta
0.5
RSI (14)
35.3

IRTC Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

IRTC Fundamentals

IRTC valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$221.59M
Net income
-$29.85M
Free cash flow
-$11.55M
View full IRTC fundamental analysis

IRTC Technical Analysis

IRTC technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Strong Sell
RSI 14
35.33
Price vs SMA-50
-17.76%
View full IRTC technical analysis

IRTC Stock Catalysts

Track IRTC earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Feb 18, 2027
Analyst target
$177.00
News items
2
View IRTC earnings and stock catalysts

IRTC Dividend Analysis

IRTC dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
—
View IRTC dividend history and analysis

IRTC Financial Data

IRTC revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$221.59M
EPS
-$0.90
Periods
8
View IRTC financials

IRTC Risk Analysis

IRTC volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
0.5
Risk score
44/100
1Y volatility
54.02%
View IRTC risk analysis

IRTC Stock News

IRTC stock news, market tone, recent headlines, and catalyst context.

News items
2
Updated
Nov 18, 2026
Sentiment
—
Read IRTC stock news

IRTC vs Medical - Devices Peers

Current peer cohort: IRTC · ITGR · LIVN · NEOG · PACB. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
IRTC
Current stock
44/10043/10034/10044/100-0.9154.02%Current
ITGR
Integer Holdings Corporation
——85/10080/1002.0231.24%IRTC vs ITGR
LIVN
LivaNova PLC
71/10060/10083/10071/1001.3839.16%IRTC vs LIVN
NEOG
Neogen Corporation
63/10049/10074/10057/1001.1957.93%IRTC vs NEOG
PACB
Pacific Biosciences of California, Inc.
48/10023/10084/10024/1000.6193.55%IRTC vs PACB
Pairwise Compare links: ITGR · LIVN · NEOG · PACBIRTC vs ITGRIRTC vs LIVNIRTC vs NEOGIRTC vs PACBCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 18, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 18, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a IRTC stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for IRTC: historical return with reinvested dividends, dollar-cost averaging (DCA) backtest and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 19, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
-76.64
As of Nov 18, 2026
Revenue growth
14.88%
Gross margin
72.26%
Current debt / equity
4.1
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$221.59M
Quarter net income
-$29.85M
Quarter free cash flow
-$11.55M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bearish
Momentum
Bearish
RSI 14
35.33
MACD
-5.89

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
44/100
Beta
0.5
Annual volatility
54.02%
Max drawdown
-54.53%

IRTC Stock FAQ

What is IRTC stock price today?

iRhythm Technologies, Inc.'s current stock price is $94.87. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is IRTC bullish or bearish right now?

IRTC's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is IRTC's market cap?

IRTC's market cap is $3.04B based on the latest completed market-close snapshot from Nov 18, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is IRTC's current P/E ratio?

IRTC's current P/E ratio is -76.64 based on the latest completed market-close snapshot from Nov 18, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is IRTC's RSI?

IRTC's 14-day RSI is 35.33 based on the latest completed market-close snapshot from Nov 18, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is IRTC above its 50-day and 200-day moving averages?

IRTC is -17.76% from its 50-day SMA and -23.15% from its 200-day SMA based on the latest completed market-close snapshot from Nov 18, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is IRTC's next earnings date?

IRTC's next earnings date is currently listed as Feb 18, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does IRTC pay a dividend?

IRTC's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 18, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.